Welcome to Coulter Partners Global (English)

12 December 2023

Top global hires for large-cap, mid-cap and public companies H2-2023

Recent top global hires for large-cap, mid-cap, and public companies, covering a broad range of disciplines and sectors across Life Sciences, Health and Tech.

CEO/ C-suite/ Board

Function Focus area Location
CEO Novel enzymes (publicly listed) Nordics
Chief Commercial Officer Specialty pharma (mid-cap) Europe
Chief Medical Officer Biopharma (publicly listed) US
Chief Financial Officer Biotech (publicly listed) US
Chief of Staff Medtech (mid-cap) Europe
Board Director Biopharma (publicly listed) Europe
Board Director Biotech (publicly listed) US

Commercial / Functional / Strategic Leadership

Function Focus area Location
Regional VP N. Europe & Australia Biopharma (large-cap) Europe/ APAC/ US
SVP Finance Biopharma (mid-cap) US
VP People, Americas Prosthetics (mid-cap) US/ Nordics
VP Marketing Biopharma (publicly listed) US
VP Product Ophthalmic technology (mid-cap) Europe
Global Head of Marketing Specialty ingredients (large-cap) Nordics
Head of Business Development Biopharma (publicly listed) Europe
Global Key Account Manager Specialty chemicals (large-cap) Europe
Senior Communications Leader Global pharma (large-cap) Europe
SE Asia, Japan, China Area Director Animal health (large-cap) APAC/ Europe
Commercial Director Digital health (publicly listed) Europe

R&D/ Medical/ Technical

Function Focus area Location
Global R&D Director ORS Engineering Surgical products (mid-cap) Nordics
Head of Neuroscience Pharma (mid-cap) Europe
Head of Rheumatology Generics (large-cap) APAC/ Europe
VP Regulatory Affairs Pharma (mid-cap) Europe/US
Global Compliance Director Specialty pharma (mid-cap) Europe
Senior Medical Director Women’s health (publicly listed) US
Medical Director, Canada Biotech (large-cap) US/Canada
Regulatory Strategy Director, Specialist Nutrition Food products (large-cap) Europe
Clinical Development Director Specialty pharma (large-cap) Europe

Related

A new version of Coulter Partners is available.